France digital PCR (dPCR) and real-time PCR (qPCR) market is expected to grow at a CAGR of 7.8% during the forecast period. France is one of the leading France biotech eco-systems along with Germany and UK. The increasing R&D in the life sciences sector is one of the major factors that is driving the growth of the market of dPCR and qPCR in the country. The other factors that are driving the growth of the dPCR and qPCR market include the extensive R&D in gene therapy techniques, infectious medicine, and the treatment of diseases such as cancer, metabolic diseases, and CVD. Along with this, as the dPCR and qPCR has a significant application in cell and gene therapy development, the market for dPCR and qPCR in France is expected to hold a considerable share in the global market. France has a strong pharmaceutical industry with 32 biomanufacturing sites generating more than 19% revenue in pharmaceutical production and 8.6% of total employment in the sector. Within the country, there is a heavy concentration of biomanufacturing sites in the Rhône-Alpes region and the Paris Basin. 

The companies operating in the country include bioMérieux S.A., Stilla Technologies, Qiagen N.V., Analytik Jena AG, Thermo Fisher Scientific Inc., and Eppendorf AG. bioMérieux S.A. offers several technologies and systems such as include automated VITEK 2 system and Etest for identifying bacteria and analyzing their susceptibility to antibiotics. It also includes a mass spectrometry-based system, VITEK MS for the identification of fungi, bacteria, and mycobacteria. The company also offers immunoassays products such as VIDAS, bioNexia and VIKIA range of products for rapid tests. Moreover, the company provides molecular biology products such as NucliSENS easyMAG and NucliSENS miniMAG, and ARGENE and NucliSENS EasyQ. For instance, in November 2018, the company got the US FDA approval for BIOFIRE FILMARRAY Pneumonia Panel and the CE-Mark of the BIOFIRE FILMARRAY Pneumonia Panel plus. The BIOFIRE FILMARRAY has used real-time PCR quantification capabilities for the first time in semi-quantitative levels for 15 bacteria which may aid clinicians to differentiate colonization from true invasive infection.

Research Methodology

The market study of the France dPCR and qPCR market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include:

• Financial reports of companies involved in the market
• Whitepapers, research-papers, and news blogs
• Company websites and their product catalog

The report provides an in-depth analysis of pricing, market size, intended quality of the product preferred by consumers. It will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

1. France dPCR and qPCR Market Research and Analysis, By Technology
2. France dPCR and qPCR Market Research and Analysis, By Product
3. France dPCR and qPCR Market Research and Analysis, By Application

The Report covers:

• Comprehensive research methodology of the France dPCR and qPCR market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the France dPCR and qPCR market.
• Insights about market determinants which are stimulating the France dPCR and qPCR market.
• Detailed and extensive market segments with regional distribution of forecast revenues.
• Extensive profiles and recent developments of market players.